More rapid, automated, and complete myeloid genomic profiling

Myeloid testing should be fast. However, myeloid malignancy samples can be challenging to analyze. They are complex, heterogeneous, and have the potential to proliferate rapidly. To get meaningful genetic insights, you need a rapid and streamlined approach for studying all key mutations.

The Impact of Fast NGS Molecular Profiling in Myeloid Malignancy Research

At EHA 2022, Dr. Dolors Colomer discussed the impact that the Oncomine Myeloid Assay GX had on turnaround times and laboratory efficiency. She presented compelling data on FLT3-ITD, showing 100% concordance between NGS and fragment analysis and the ability to detect low-frequency variants ranging in size from 12–180 bp.

Dolors Colomer, PhD

Head of Hematopathology
Hospital Clinic, IDIBAPS,
University of Barcelona, Spain


Oncomine Myeloid Assay GX v2

The Ion Torrent Oncomine Myeloid Assay GX V2 on the Ion Torrent Genexus System provides a complete next-generation sequencing (NGS) solution that can deliver a comprehensive myeloid mutational report in as little as 24 hours.

Profile all key myeloid mutations with one test

Simultaneously interrogate 45 DNA target genes and 34 fusion driver genes (RNA). This broad fusion panel allows you to sequence over 800 unique fusion transcripts. Gene content on the panel has been curated to cover relevant targets for all the major myeloid disorders—AML, MDS, MPN, CML, CMML, and JMML.

Complete coverage of key genes

Detect multiple types of mutations at once

 

Myeloid samples frequently harbor mutations in difficult-to-sequence regions of the genome. The Oncomine Myeloid Assay GX v2 has been carefully engineered to reliably detect all relevant mutations associated with myeloid malignancies, including targets in challenging genes like CEBPA, FLT3, CALR and more.

 

  • Single nucleotide variants
  • Insertions and Deletions
  • Tandem duplications
  • Gene fusions

View scientific posters

2024 AACR Poster

Detection of KMT2A-PTDs in healthy donor and myeloid malignant samples using next generation sequencing

2024 AMP Poster

Development of an automated genomic profiling assay for myeloid malignancies research

2023 AACR Poster

Fully automated sample-to-report NGS workflow for comprehensive genomic profiling of myeloid research samples


It's NGS made easy

A highly integrated workflow lets you go from specimen to report in as little as 20 minutes of hands-on time required. It’s never been easier to implement myeloid NGS testing in your lab.


Automate your workflow from specimen to report

Start with any common myeloid specimen type, including whole blood, bone marrow, or peripheral blood leukocytes. From there, the Genexus System integrates and automates nucleic acid extraction, purification, quantification, library preparation, sequencing, analysis and reporting within a single software ecosystem. 

Whole Blood

Peripheral Blood Leukocytes (PBLs)

Bone Marrow

Nucleic acid extraction and quantification

Library preparation

Sequencing

Reporting & analysis

Biomarkers linked to relevant evidence from

public data sources


Clear and concise reports

Ion Torrent Oncomine Reporter is a curated knowledgebase and reporting software that links biomarkers to relevant evidence and enables custom reporting. These tools help simplify the bioinformatics workflow and enable you to focus on finding the biological meaning of your data.


Ordering information


Ready to speak to a Thermo Fisher representative?

We will be happy to answer your questions and provide a demo of our NGS solutions.

For Research Use Only. Not for use in diagnostic procedures.